Adage Capital Partners, L.P. is 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 19 open-market trades across 9 companies since 2011, most recently 2023-05-10.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $17.2M since 2012, against 11 sales. Across 8 scored buys the stock is down 3.4% at ninety days, and 3.7 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 13% | 13% |
| Avg Move | -35.2% | -3.4% | -3.4% |
| Alpha | -29.4% | -3.7% | -3.7% |
| Scored | 8 | 8 | 8 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 89% | 33% | 25% |
| Avg Move | -5.0% | +0.6% | +8.5% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GCMG | SELL | 2023-05-08 | 2023-05-10 | $7.51 | $2.9M | -1.1% | -4.1% | +6.7% |
| GCMG | SELL | 2023-05-03 | 2023-05-05 | $7.83 | $4.9M | -9.2% | -10.3% | +2.8% |
| ORBC | SELL | 2019-11-20 | 2019-11-22 | $4.04 | $996K | -2.4% | +2.2% | -1.7% |
| PBYI | SELL | 2017-06-05 | 2017-06-05 | $91.28 | $27.8M | -6.5% | +4.6% | +15.3% |
| PBYI | SELL | 2017-06-02 | 2017-06-05 | $83.06 | $2.5M | -6.5% | +4.6% | +15.3% |
| PBYI | SELL | 2017-06-01 | 2017-06-05 | $87.85 | $43.8M | -6.5% | +4.6% | +15.3% |
| PBYI | SELL | 2017-06-01 | 2017-06-05 | $82.44 | $14.0M | -6.5% | +4.6% | +15.3% |
| VTAE | SELL | 2016-09-14 | 2016-09-16 | $20.85 | $21.4M | +0.1% | +0.4% | N/A |
| PSUN | SELL | 2016-04-05 | 2016-04-07 | $0.10 | $934K | N/A | N/A | N/A |
| CALA | BUY | 2015-09-03 | 2015-09-08 | $5.93 | $536K | -32.6% | +0.3% | +0.3% |
| PBYI | BUY | 2013-11-08 | 2013-11-12 | $38.92 | $878K | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2013-10-09 | 2013-10-11 | $40.44 | $5.7M | -37.6% | -4.0% | -4.0% |
| BDBD | SELL | 2013-01-31 | 2013-02-04 | $13.52 | $4.1M | N/A | N/A | N/A |
| PBYI | BUY | 2012-12-18 | 2012-12-20 | $19.00 | $562K | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2012-06-29 | 2012-07-03 | $11.05 | $2.0M | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2012-05-01 | 2012-05-03 | $13.25 | $179K | -37.6% | -4.0% | -4.0% |
| PBYI | BUY | 2012-04-26 | 2012-05-01 | $13.70 | $1.7M | -37.6% | -4.0% | -4.0% |
| AMAG | BUY | 2012-03-01 | 2012-03-05 | $15.55 | $5.7M | -23.6% | -3.6% | -3.6% |
| SCSS | SELL | 2011-02-04 | 2011-02-08 | $10.20 | $3.3M | -6.6% | -1.0% | -1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| PSUN | 7,532,806 | $312K |
| BDBD | 5,941,092 | — |
| Total | $485.1M |
Shares reported on the most recent Form 4, priced at the 2023-05-10 close. 1 holding could not be priced and is excluded from the total.
| Scored | 9 | 9 | 8 |